The Nomination and Remuneration Committee (NRC) approved the allotment through Circular Resolution passed on November 18, 2026. The committee approved allotment of 10,000 equity shares of face value of ₹2 each fully paid-up to an options grantee who exercised vested options under the 'Renaissance Global – Employee Stock Option Scheme 2021' (RGL ESOP 2021).
The equity shares allotted are fully paid-up and shall rank pari passu with the existing equity shares of the company in all respects. The company will apply for listing of these 10,000 equity shares on both National Stock Exchange of India Limited and BSE Limited.
Capital Structure Impact
Consequent to this allotment, the paid-up equity share capital of the company has increased:
- From: ₹21,49,30,442 comprising 10,74,65,221 equity shares of ₹2 each
- To: ₹21,49,50,442 comprising 10,74,75,221 equity shares of ₹2 each
The distinctive numbers of the allotted shares range from 10,74,65,222 to 10,74,75,221 (both inclusive).
ESOP Scheme Details
The RGL ESOP 2021 scheme was approved by shareholders through postal ballot on January 21, 2022. The total scheme covers 25,00,000 equity shares (each option convertible into one equity share of ₹2 face value).
Grant Details:
- Grant-1: 6,25,000 options (exercise price ₹110 each)
- Grant-2: 8,05,000 options (exercise price ₹110 each)
- Grant-3: 30,000 options (exercise price ₹110 each)
- Grant-4: 3,59,562 options (exercise price ₹2 each)
- Grant-5: 51,000 options (exercise price ₹2 each)
- Grant-6: 1,07,140 options (exercise price ₹2 each)
- Grant-7: 51,000 options (exercise price ₹2 each)
- Total granted: 20,28,702 options
Current Exercise Details:
- Options exercised: 10,000 options from Grant-2
- Exercise price per share: ₹110
- Premium per share: ₹108
- Money realized: ₹11,00,000
- Total shares arising: 10,000 equity shares of ₹2 each
Vesting History:
The document provides detailed vesting history for each grant, including cancellations due to resignations and surrenders/relinquishments by grantees.
Options Lapsed:
- Grant-1: 98,750 options lapsed
- Grant-2: 2,99,000 options lapsed
- Grant-6: 53,570 options lapsed
Additional Information
- Diluted earnings per share pursuant to issue: 1.84 per share
- No lock-in restrictions apply to the allotted shares
- No listing fees payable
- The shares are identical in all respects to existing shares